HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

882.904

+4.4170.50%

Number of Gainers:7

Number of Losers:8

Number of Flat:2

PE:- -

High:884.571

Open:878.433

Low:868.104

Close:878.487

Volume:58.50M

Turnover:468.94M

Market Cap:596.85B

Float Cap:494.09B

Loading ...

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection

CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS

Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9

Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong

Sinopharm Group Stock Slips 2.1% in Hong Kong

BYD Electronic (International) Stock Sheds 2.4% in Hong Kong

Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors

JD Health International Stock Sheds 3.7% in Hong Kong

AH Share Premium Rankings as of September 9 Trading Close

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Dizal Pharmaceutical's Birelentinib Shows Promise in Lymphoma Study Published in Blood Cancer Journal

BOC International sees pharma sector earnings recovery as industry enters a reversal cycle

Ascletis Hits 4-Week High on Initiating US Phase I Study on Obesity Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK1515/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":882.90424,"timestamp":1789612033889,"preClose":878.48724,"halted":0,"volume":58502722,"delay":0,"changeRate":0.005028,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":4.416992,"latestTime":"09-17 10:27:14","open":878.4325,"high":884.57117,"low":868.10425,"amount":468939844,"amplitude":0.018745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789617600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.000801,"increases":7,"decrements":8,"flats":2,"marketCap":596854446208,"floatMarketCap":494092270592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":884.57117,"amplitude":0.018745,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":882.90424,"volume":58502722,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.000801,"peRate":17.071131,"marketCap":596854446208,"floatMarketCap":494092270592,"timestamp":1789612033889,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":7,"down":8,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1145691069","title":"Trump Unveils Midterm Strategy: Tax Cuts and \"MAHA Movement\" Take Center Stage, Targeting Pharma and Processed Food Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1145691069","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145691069?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:44","pubTimestamp":1788961466,"startTime":"0","endTime":"0","summary":"President Trump has stepped up his campaign efforts ahead of the November midterm elections, adopting a familiar playbook of self-promotion that he has long relied upon. Despite approval ratings...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","159151","09939","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108076077","title":"Fosun Pharma's New Oral Drug for Vitiligo Gets Green Light for Phase III Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1108076077","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108076077?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956512,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. has announced that its oral candidate FXS5626 tablets (formerly project code AC-201) have received clinical trial approval from the National Medical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0175","BK0196","BK1191","BK1515","600196","BK0183","02196","BK0012","BK0060","BK0096","BK0187","BK0188","BK0028","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497303","title":"Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497303","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179497303?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:14","pubTimestamp":1788956052,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 9, 2026, the company spent HK$1.9608 million to repurchase 75,000 shares.The buyback transaction reflects the company's ongoing capital management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","02595","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587876","title":"CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587876","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587876?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951640,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH9102 injection obtained clinical trial approval from China's National Medical Products Administration.The clinical indication is for patients with solid tumors, according to a Wednesday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01093","LU1226287529.USD","LU1226287792.SGD","LU0315179316.USD","LU1813983027.USD","LU0880133367.SGD","BK1191","LU1008478684.HKD","LU0072913022.USD","LU1152091754.HKD","LU1226287875.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1226288253.USD","LU1993786604.SGD","LU2039709279.SGD","KURE","LU1951186391.HKD","LU1807302812.USD","HK0000165453.HKD","LU0140636845.USD","IE00B031HY20.USD","LU0326950275.SGD","LU1328277881.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","BK1515","BK1521","IE0008369823.USD","IE0008368742.USD","LU1152091168.USD","SG9999004220.SGD","LU1960683339.HKD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU0314109678.HKD","IE00BZ08YR35.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666828235","title":"CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666828235","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666828235?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:34","pubTimestamp":1788950057,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval In ChinaSept 9 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:ROTIGOTINE LONG-ACTING INJECTION (SYH9087 INJECTION) OBTAINS CLINICAL TRIAL APPROVAL IN CHINAFurther company coverage:1093.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN45104B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","BK1191","LU1951186391.HKD","LU1807302812.USD","IE0008368742.USD","LU0326950275.SGD","LU1226287792.SGD","LU1226288253.USD","IE00B543WZ88.USD","LU0501845795.SGD","IE00BZ08YR35.GBP","LU0072913022.USD","LU1226288170.HKD","LU1008478684.HKD","LU2039709279.SGD","LU1226287875.USD","IE00B031HY20.USD","BK1521","LU0315179316.USD","IE00BZ08YS42.EUR","01093","LU1226287529.USD","LU1328277881.USD","LU0067412154.USD","LU0140636845.USD","LU1152091168.USD","IE00B5MMRT66.SGD","SG9999004220.SGD","IE0008369823.USD","LU0314109678.HKD","LU1993786604.SGD","HK0000165453.HKD","LU1152091754.HKD","LU0880133367.SGD","BK1515","LU1960683339.HKD","LU1813983027.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151768833","title":"CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1151768833","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151768833?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","IE00BZ08YS42.EUR","LU2039709279.SGD","LU1152091754.HKD","HK0000165453.HKD","LU0314109678.HKD","LU1226287875.USD","BK1521","LU0140636845.USD","LU1226288253.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","BK1515","BMED","SG9999004220.SGD","LU1226288170.HKD","LU1226287792.SGD","MDTX","IE0008369823.USD","LU1008478684.HKD","BK1191","LU1813983027.USD","LU0326950275.SGD","LU1152091168.USD","IE0008368742.USD","LU1807302812.USD","IE00B5MMRT66.SGD","IBBQ","LU0315179316.USD","01093","LU1960683339.HKD","IBBJ","LU0072913022.USD","LU1951186391.HKD","LU1993786604.SGD","IE00B031HY20.USD","LU0880133367.SGD","IE00B543WZ88.USD","LU1226287529.USD","PSYK","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100647125","title":"CSPC Pharma Gains Chinese Clinical Trial Approval for Goserelin Extended-Release Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1100647125","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100647125?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:12","pubTimestamp":1788948739,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its self-developed gonadotropin-releasing hormone (GnRH) receptor agonist, Goserelin Extended-Release Injection (SYH9102 Injection), has received approval from...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","01093","IBBJ","LU1807302812.USD","KURE","LU1328277881.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU1152091754.HKD","LU0140636845.USD","BK1191","LU0326950275.SGD","LU1226288170.HKD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","PSYK","LU1152091168.USD","LU0314109678.HKD","IBBQ","LU1226287529.USD","HK0000165453.HKD","LU1226287875.USD","LU1993786604.SGD","LU0880133367.SGD","BK1515","IE00BZ08YT58.USD","IE0008369823.USD","BK1521","SG9999004220.SGD","LU0072913022.USD","MDTX","LU0067412154.USD","LU1960683339.HKD","LU1226288253.USD","LU1008478684.HKD","BMED","IE00B031HY20.USD","LU0315179316.USD","LU2039709279.SGD","IE0008368742.USD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666610584","title":"CSPC Pharma Wins China Clinical Trial Clearance for Syh9102 Goserelin Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2666610584","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666610584?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948662,"startTime":"0","endTime":"0","summary":"CSPC Pharma wins China clinical trial clearance for SYH9102 goserelin injectionCSPC Pharmaceutical Group received China NMPA clearance to start clinical trials of its goserelin sustained-release injec","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9BYJhM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","LU1807302812.USD","LU2039709279.SGD","LU0315179316.USD","BK1521","IE00B031HY20.USD","KURE","IE0008369823.USD","LU1008478684.HKD","IE00BZ08YT58.USD","LU1993786604.SGD","SG9999004220.SGD","LU1226288253.USD","LU1226287792.SGD","LU0067412154.USD","IE00B5MMRT66.SGD","BK1191","IE00BZ08YR35.GBP","LU1226288170.HKD","LU1951186391.HKD","LU1226287529.USD","LU1226287875.USD","LU1152091754.HKD","LU1813983027.USD","LU0326950275.SGD","LU1328277881.USD","IE0008368742.USD","BK1515","IE00B543WZ88.USD","LU0140636845.USD","LU0880133367.SGD","LU0072913022.USD","LU1960683339.HKD","LU1152091168.USD","01093","LU0501845795.SGD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584556","title":"CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584556?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:07","pubTimestamp":1788948434,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN450126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0067412154.USD","LU1813983027.USD","HK0000165453.HKD","LU1152091168.USD","LU1152091754.HKD","LU0072913022.USD","LU1226288170.HKD","LU0314109678.HKD","LU0501845795.SGD","LU1328277881.USD","LU1226287792.SGD","IE0008369823.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU0140636845.USD","KURE","LU1226287875.USD","IE00B031HY20.USD","LU1960683339.HKD","LU1951186391.HKD","LU2039709279.SGD","LU0880133367.SGD","SG9999004220.SGD","IE00B543WZ88.USD","IE0008368742.USD","IE00BZ08YR35.GBP","01093","LU1993786604.SGD","BK1521","LU0315179316.USD","IE00BZ08YS42.EUR","IE00B5MMRT66.SGD","BK1191","LU1226288253.USD","LU0326950275.SGD","LU1008478684.HKD","LU1226287529.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156059034","title":"Fosun Pharma Spends HK$2.63 Million Buying Back Shares on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1156059034","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156059034?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:06","pubTimestamp":1788948375,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has announced that on September 9, 2026, the company repurchased 152,500 shares for a total consideration of HK$2.63 million.The buyback transaction was disclosed in an official...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0187","BK1515","BK0012","600196","BK0196","BK0175","BK0096","BK0239","BK0188","02196","BK1593","BK0183","BK1191","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666585460","title":"Alibaba Health Information Technology Stock Slips 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585460","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585460?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. shed 2.9% to 3.05 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.Alibaba Health Information Technology Ltd. closed 61% short of its 52-week high of HK$7.91, which the company reached Jan. 14.The stock underperformed when compared to some of its competitors, as HKT Trust & HKT Ltd. fell 0.1%.Trading volume totaled 82.0 million shares, compared to the 50-day average of 97.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["83115","09115","BK1589","HHImain","BK1615","513600","BK1584","07200","03419","02800","BK1502","03037","BK1247","07500","07300","BK1142","MCHmain","HK0000165453.HKD","BK1610","02833","82800","BK1591","BK1617","MHImain","BK1189","BK1515","00241","HSTECH","HSI","BK1501","BK1571","03115"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666458549","title":"Sinopharm Group Stock Slips 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666458549","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666458549?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slid 2.1% to 15.70 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.The stock's fall snapped a four-day winning streak.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.2%.Trading volume totaled 5.9 million shares, compared to the 50-day average of 5.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1500","BK0028","BK0196","600196","BK0096","BK1515","BK1197","LU0640798160.USD","LU1115378108.SGD","BK0060","BK0183","BK0188","BK0187","BK1191","BK0175","BK4175","01099","SHTDY","02196","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666427585","title":"BYD Electronic (International) Stock Sheds 2.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666427585","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666427585?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:32","pubTimestamp":1788942720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. slipped 2.4% to 24.90 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's second consecutive day of losses.BYD Electronic  Co. Ltd. closed 44% below its 52-week high of HK$44.60, which the company reached Oct. 2.Despite its losses, the stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 3.1%.Trading volume totaled 9.3 million shares, compared to the 50-day average of 12.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1580","LU0274383008.USD","00285","BK1515","LU0348767384.USD","BK1149","BK1582","BK1167","BK1504","BK1607","BK1589","LU0348766576.USD","BK1540"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666854905","title":"Sino Biopharmaceutical Stock Slides 4.0% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666854905","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666854905?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:31","pubTimestamp":1788942660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. slid 4.0% to 5.61 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.Sino Biopharmaceutical Ltd. closed 38% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 3.4% and Amgen Inc. remained unchanged.Trading volume totaled 97.7 million shares, compared to the 50-day average of 100.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","BK1191","LU1057294990.SGD","IBBQ","LU2112291526.USD","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","01177","AMGN","IE00BZ08YS42.EUR","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","IE00BZ08YR35.GBP","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","BK4534","LU2089984988.USD","BK1521","BIB","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4139","LU0109394709.USD","BK1589","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","BK1515","LU2468319806.SGD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","HK0000165453.HKD","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666585445","title":"JD Health International Stock Sheds 3.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2666585445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666585445?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:30","pubTimestamp":1788942600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. shed 3.7% to 35.26 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.2% to 25274.96.This was the stock's third consecutive day of losses.JD Health International Inc. closed 51% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 20.2 million shares, compared to the 50-day average of 9.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","SGXZ62798434.SGD","LU0456827905.SGD","86618","SGXZ86797644.SGD","BK1142","06618","BK1247","BK1589","BK1591","BK1615","BK1571","LU0051755006.USD","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194600066","title":"AH Share Premium Rankings as of September 9 Trading Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1194600066","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194600066?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:24","pubTimestamp":1788942275,"startTime":"0","endTime":"0","summary":"As of the market close on September 9, three companies lead the A-H share premium rankings for the session. NE ELECTRIC (00042) tops the list with a premium of 1121.72%, followed by ZHEJIANG SHIBAO...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1282648689.USD","LU0449509016.USD","LU0106959298.USD","BK1163","03308","LU1988902786.USD","BK1149","LU0543330483.HKD","LU0164939612.USD","LU0572944931.SGD","LU0181495838.USD","BK1148","LU2097828474.EUR","LU0164865239.USD","LU0254981946.USD","LU0307460666.USD","LU2097828805.USD","00317","LU1244550221.USD","SG9999014674.SGD","06869","BK1147","BK1515","03200","BK1190","LU0328353924.USD","LU1244550494.USD","01033","02827","BK1546","LU0329678170.USD","LU1046422090.SGD","LU2097828557.USD","BK1198","LU2264538146.SGD","HK0001040143.USD","BK1544","LU1960683339.HKD","LU1152091168.USD","00553","00991","LU1504937902.USD","02338","IE00B0169L03.USD","LU2399975544.HKD","HK0000306685.HKD","159982","LU0509642566.USD","LU0620787316.HKD","LU1655091616.SGD","03328","03130","LU0029875118.USD","LU1961090484.USD","LU0269904917.USD","HK0001040168.HKD","LU2226246903.HKD","LU0561508036.HKD","LU1808992512.USD","BK1161","BK1514","LU1719994722.HKD","LU2177674079.SGD","LU0082770016.USD","02068","LU0417516902.SGD","BK1506","LU0463099449.HKD","LU0173614495.USD","LU1244550577.SGD","LU0828237510.HKD","LU1831875114.USD","LU1255011170.USD","BK1122","LU1769817096.USD","LU0431992006.USD","LU1152091754.HKD","LU0266512473.USD","LU0348766576.USD","06066","01276","BK1552","EWH","BK1141","LU0359201885.HKD","LU0918141887.USD","BK1530","LU0868486357.SGD","BK1560","BK1191","LU2008162690.USD","LU0348735423.USD","LU0061477393.USD","LU0588546209.SGD","BK1583","HK0000320223.HKD","BK1214","LU0370786039.SGD","LU0871576103.HKD","03750","IE0034224299.USD","LU1064131342.USD","BK1237","06821","LU0359202008.SGD","BK1183","LU2045819591.USD","LU2242644610.SGD","LU0067412154.USD","01108","83188","LU0359201612.USD","LU0456854461.SGD","LU0049853897.USD","BK1110","02475","LU0737861699.HKD","BK1140","BK1537","LU1242518931.SGD","LU1251922891.USD","LU0211977185.USD","LU0228659784.USD","LU0345780281.USD","BK1125","82846","01057","LU0039217434.USD","LU0348767384.USD","LU0531971595.HKD","LU0149721374.USD","02359","LU0326950275.SGD","LU0348825331.USD","LU2097828631.EUR","00895","LU0314109678.HKD","BK1533","IE00BZ08YS42.EUR","LU0797268264.HKD","07233","BK1171","LU1993786604.SGD","LU0345780521.USD","LU0128522157.USD","LU0348816934.USD","LU0106252389.USD","LU0979878070.USD","LU0828237940.HKD","LU1206782309.USD","LU0828238088.HKD","BK1576","SG9999001093.SGD","BK1551","LU0607220059.USD","LU1303224171.USD","01812","LU0821914370.USD","LU0348827113.USD","01877","01349","LU0287142896.SGD","LU0052750758.USD","LU1105468828.SGD","00300","LU0320764755.SGD","LU3063872942.SGD","IE00BZ08YR35.GBP","BK1202","02218","06745","LU1720050803.USD","LU1794554557.SGD","BK1223","00042","LU0886674414.USD","LU1769817179.HKD","HK0000320264.USD","LU1023057109.AUD","LU2039709279.SGD","LU1807302812.USD","00187","BK1193","LU0165289439.USD","BK1523","BK1116","BK1554","BK1562","LU0096374516.USD","LU0417516738.SGD","LU0708995583.HKD","LU0082770016.SGD","LU0327786744.USD","LU1188198961.HKD","LU1770034418.SGD","LU0043850808.USD","LU0531970944.HKD","BK1105","09976","LU2097828714.EUR","LU1048596156.SGD","03188","LU1008478684.HKD","BK1594","LU1813983027.USD","LU1481107354.HKD","LU0149534421.HKD","BK1249","LU0140636845.USD","LU0634319403.HKD","SG9999011746.SGD","LU0164880469.USD","IE0032431581.USD","LU0320764599.SGD","LU0244354667.USD","LU0880133367.SGD","03986","BK1610","LU0737861772.HKD","BK1592","BK1170","LU2543165471.USD","LU0048580855.USD","LU1328277881.USD","02846","BK1564","LU0672654166.SGD","IE00BZ08YT58.USD","03678","LU0329678337.USD","02865","LU0540923850.HKD","LU0266512127.USD","LU2394011477.USD","LU0918141705.HKD","HK0000306701.USD","SG9999002463.SGD","SG9999004220.SGD","BK1522","83130","BK1231","SG9999006597.SGD","LU0348814723.USD","02899","BK1505","LU0214875030.USD","LU2125910500.SGD","LU1242518857.USD","LU1224709979.USD","SG9999001226.SGD","399300","LU0469268626.HKD","BK1144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143782105","title":"UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=1143782105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143782105?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:03","pubTimestamp":1788940980,"startTime":"0","endTime":"0","summary":"UBS has released a research report indicating that first-half results among Chinese pharmaceutical stocks were mixed, with five of the nine rated companies exceeding market expectations. These...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","BK1521","IE00BZ08YT58.USD","BK1589","IE00B3M56506.USD","01177","02096","BK1191","IE00BZ08YR35.GBP","BK1593","BK1583","BK1161","01530","BK1515","BK1574","03933","01477","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144997108","title":"Dizal Pharmaceutical's Birelentinib Shows Promise in Lymphoma Study Published in Blood Cancer Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=1144997108","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144997108?lang=en_us&edition=fundamental","pubTime":"2026-09-09 16:00","pubTimestamp":1788940815,"startTime":"0","endTime":"0","summary":"Dizal Pharmaceutical Co., Ltd. (688192.SH) has announced that the results of its Phase II clinical study, TAI-SHAN9, evaluating the company's first-in-class, fully brain-penetrant, non-covalent...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","688192","159938","09939","BK0239","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112577285","title":"BOC International sees pharma sector earnings recovery as industry enters a reversal cycle","url":"https://stock-news.laohu8.com/highlight/detail?id=1112577285","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112577285?lang=en_us&edition=fundamental","pubTime":"2026-09-09 11:30","pubTimestamp":1788924637,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector's interim reports for the first half of 2026 have been fully released, revealing resilient overall growth with structural improvements continuing to unfold, according to BOC...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","159938","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309337","title":"Ascletis Hits 4-Week High on Initiating US Phase I Study on Obesity Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309337","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666309337?lang=en_us&edition=fundamental","pubTime":"2026-09-09 10:03","pubTimestamp":1788919398,"startTime":"0","endTime":"0","summary":"BUZZ-Ascletis hits 4-week high on initiating US Phase I study on obesity drug** Shares of Ascletis Pharma Inc1672.HKclimb 5.6% to HK$10.75, their highest since August 13** Stock on track for biggest one-day pct gain since August 7** Pharmaceutical products producer says it hasinitiateda U.S. Phase I study of ASC36 oral tablets for treatment of obesity after receiving Investigational New Drug clearance from the U.S. Food and Drug Administration** ASC36 oral tablets reduced mean body weight up to 13.2% from baseline after once-daily dosing for seven days in non-human primates - co** YTD, stock down 7.3%, while Hang Seng Biotech Index.HSBIOup 10.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL1N451020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1574","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":179,"code":"91000000","status":"200"}]}}